These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30562840)

  • 1. Twenty-five years of research about adipogenic adenoviruses: A systematic review.
    Akheruzzaman M; Hegde V; Dhurandhar NV
    Obes Rev; 2019 Apr; 20(4):499-509. PubMed ID: 30562840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What we know and what we need to know about adenovirus 36-induced obesity.
    Kim J; Na H; Kim JA; Nam JH
    Int J Obes (Lond); 2020 Jun; 44(6):1197-1209. PubMed ID: 31942033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human adenovirus Ad36 and its E4orf1 gene enhance cellular glucose uptake even in the presence of inflammatory cytokines.
    Na HN; Dubuisson O; Hegde V; Nam JH; Dhurandhar NV
    Biochimie; 2016 May; 124():3-10. PubMed ID: 25450249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adenoviruses in obesity.
    Voss JD; Atkinson RL; Dhurandhar NV
    Rev Med Virol; 2015 Nov; 25(6):379-87. PubMed ID: 26352001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a standard protocol for quantitative polymerase chain reaction to detect adenovirus 36, which is associated with obesity.
    Hwang KA; Park S; Ahn JH; Nam JH
    Acta Virol; 2018; 62(4):350-359. PubMed ID: 30472864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin sparing action of adenovirus 36 and its E4orf1 protein.
    Dhurandhar NV
    J Diabetes Complications; 2013; 27(2):191-9. PubMed ID: 23246247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic stability of adipogenic human adenovirus 36.
    Nam JH; Na HN; Atkinson RL; Dhurandhar NV
    Int J Obes (Lond); 2014 Feb; 38(2):321-4. PubMed ID: 23732658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease.
    Trovato GM; Martines GF; Garozzo A; Tonzuso A; Timpanaro R; Pirri C; Trovato FM; Catalano D
    Liver Int; 2010 Feb; 30(2):184-90. PubMed ID: 19840251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus 36 attenuates weight loss from exercise but improves glycemic control by increasing mitochondrial activity in the liver.
    Na HN; Hong YM; Ye MB; Park S; Kim IB; Nam JH
    PLoS One; 2014; 9(12):e114534. PubMed ID: 25479564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E4orf1: a novel ligand that improves glucose disposal in cell culture.
    Dhurandhar EJ; Dubuisson O; Mashtalir N; Krishnapuram R; Hegde V; Dhurandhar NV
    PLoS One; 2011; 6(8):e23394. PubMed ID: 21886789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies.
    Yamada T; Hara K; Kadowaki T
    PLoS One; 2012; 7(7):e42031. PubMed ID: 22848697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adenovirus-derived protein: A novel candidate for anti-diabetic drug development.
    Hegde V; Na HN; Dubuisson O; Burke SJ; Collier JJ; Burk D; Mendoza T; Dhurandhar NV
    Biochimie; 2016 Feb; 121():140-50. PubMed ID: 26700141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human obesity relationship with Ad36 adenovirus and insulin resistance.
    Trovato GM; Castro A; Tonzuso A; Garozzo A; Martines GF; Pirri C; Trovato F; Catalano D
    Int J Obes (Lond); 2009 Dec; 33(12):1402-9. PubMed ID: 19786969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus 36 improves glycemic control and markers of Alzheimer's disease pathogenesis.
    Hegde V; Vijayan M; Kumar S; Akheruzzaman M; Sawant N; Dhurandhar NV; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165531. PubMed ID: 31398466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection.
    Lin WY; Dubuisson O; Rubicz R; Liu N; Allison DB; Curran JE; Comuzzie AG; Blangero J; Leach CT; Göring H; Dhurandhar NV
    Diabetes Care; 2013 Mar; 36(3):701-7. PubMed ID: 23160725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate identification of neutralizing antibodies to adenovirus Ad36, -a putative contributor of obesity in humans.
    Dubuisson O; Day RS; Dhurandhar NV
    J Diabetes Complications; 2015; 29(1):83-7. PubMed ID: 25312598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36.
    Na HN; Nam JH
    Int J Obes (Lond); 2014 Nov; 38(11):1470-4. PubMed ID: 24614097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of adipose tissue macrophages and macrophage-derived insulin-like growth factor-1 in virus-induced obesity.
    Park S; Park HL; Lee SY; Nam JH
    Int J Obes (Lond); 2016 Mar; 40(3):460-70. PubMed ID: 26395748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation.
    Na HN; Nam JH
    J Infect Dis; 2012 Mar; 205(6):914-22. PubMed ID: 22275403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking Study About Adenovirus 36 Infection: Increase of Adiposity.
    Park S; Kim J; Shin HJ; Hong YM; Sheen YH; Park HL; Jeon HJ; Ahn SY; Nam JH
    J Microbiol Biotechnol; 2015 Dec; 25(12):2169-72. PubMed ID: 26428735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.